Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery
1 other identifier
observational
40
1 country
1
Brief Summary
Prospective 2-arm cohort consisting of a preoperative visit and visits at the time of implantation (Day 0) and follow-up in patients for whom their treating physician indicated a perimodiolar or straight cochlear implant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2021
CompletedFirst Submitted
Initial submission to the registry
October 3, 2021
CompletedFirst Posted
Study publicly available on registry
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2023
CompletedOctober 15, 2021
October 1, 2021
1.4 years
October 3, 2021
October 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Amplitude of cochlear microphonics
Postoperative amplitude of cochlear microphonics
0-12 months
Secondary Outcomes (2)
Cochlear implant impedance
0-12 months
Residual hearing
0-12 months
Study Arms (2)
Perimodiolar (PM)
Patients to be implanted with: Mid Scala or CI532 / 632 (Slim modiolar) electrode
Lateral wall (PL)
Patients to be implanted with: Slim J or CI522 / 622 (Slim Lateral) electrode
Interventions
Electrode surgically implanted in patient's cochlea to improve hearing
Eligibility Criteria
All patients over 12 months of age who will receive a cochlear implant
You may qualify if:
- Patients to receive a Cochlear implant 12 Months of age or older at the time of incorporation Willingness to participate and comply with the requirements of the protocol Residual hearing better than 80 dBA at 500 Hz
You may not qualify if:
- Medical or pharmacological comorbid condition that contraindicates cochlear implantation.
- Surgical impossibility to follow the guidelines of the minimally traumatic technique.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Italiano de Buenos Aires
Capital Federal, Buenos Aires, C1199ABB, Argentina
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Federico A Di Lella, MD PhD
Hospital Italiano de Buenos Aires
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
October 3, 2021
First Posted
October 15, 2021
Study Start
July 19, 2021
Primary Completion
December 19, 2022
Study Completion
December 19, 2023
Last Updated
October 15, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD to other researchers.